Eyenovia, Inc. (EYEN)
Eyenovia, Inc. (EYEN)
$3.19 USD
Updated Jul 19 12:00am
Add EYEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
EYEN News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesEyenovia, Inc. (EYEN) Company Bio
Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst that has completed Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat that has completed Phase II clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
EYEN Stock Chart More Charts
EYEN Price/Volume Stats
| Current price | $3.19 |
| Prev. close | $3.18 |
| Day low | $3.01 |
| Day high | $3.27 |
| 50-day MA | $4.54 |
| 200-day MA | $4.39 |
| 52-week high | $6.98 |
| 52-week low | $2.40 |
| Volume | 167,300 |
| Avg. volume | 174,177 |
| Dividend yield | N/A |
| Market Cap | 38.45M |
EYEN Returns
| 1-mo | -27.00% |
| 3-mo | -50.39% |
| 6-mo | 9.62% |
| 1-year | -50.92% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 11.93% |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
| 2014 | N/A |
Loading social stream, please wait...